1Suppliers
7Customers
3Debt Items
4Related Chains

Vericel Corporation Suppliers

TickerNameConfidenceEvidence
ALLCARE-PLUS-PHARMACY-INC ALLCARE-PLUS-PHARMACY-INC 90% The Company contracts with two specialty pharmacies, Orsini Pharmaceutical Services, Inc. ("Orsini") and AllCare Plus Pharmacy, Inc. ("AllCare") to distribute MACI in a manner in which the Company re…

Vericel Corporation Customers

TickerNameConfidenceEvidence
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES 95% USAspending awards from Department of Health and Human Services: $34,880,933 across 1 awards. 75A50126C00002 NON SURGICAL DEBRIDEMENT | Qwen corrected direction: Explicit government contract awards f…
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS 95% USAspending awards from Department of Veterans Affairs: $573,425 across 9 awards. 36C25226P0376 IMPLANT; 36C25926P0377 PROS KNEE CARTILAGE DEFECTS; 36C25926P0334 PROS IMPLANTS | Qwen corrected direct…
ALLCARE-PLUS-PHARMACY-INC ALLCARE-PLUS-PHARMACY-INC 85% tical Services, Inc. (“Orsini”) and AllCare Plus Pharmacy, Inc. (“AllCare”) to distribute MACI in a manner in which the Company retains the credit and collection risk from the end customer. The Compa…
DMS-PHARMACEUTICAL-GROUP-INC DMS-PHARMACEUTICAL-GROUP-INC 85% In addition, the Company sells MACI directly to hospitals pursuant to an agreed upon purchase order and to a distributor, DMS Pharmaceutical Group, Inc. ("DMS") at a contracted rate for the treatment…
MDWD MediWound Ltd. 72% ew manufacturing facility in Burlington, Massachusetts, the ability to sustain profitability, contributions to adjusted EBITDA, the expected target surgeon audience, potential fluctuations in sales a…
MDWD MediWound Ltd. 72% Reciprocal relationship from MDWD graph: Reciprocal relationship from VCEL graph: ew manufacturing facility in Burlington, Massachusetts, the ability to sustain profitability, contributions to adjust…
INSIDER-TRADING-COMPLIANCE-OFFICER-VERICEL-CORPO INSIDER-TRADING-COMPLIANCE-OFFICER-VERICEL-CORPO 62% Officer. G. Is This Insider Trading Policy Subject to Modification? The Company may at any time change this Insider Trading Policy or adopt such other policies or procedures which it considers approp…

Vericel Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
VCEL-DEBT Debt stack $95.0M 90% Market cache reports total debt of $95.0M.
VCEL-DEBT-13307 Xbrl Convertible 90% xbrl convertible detail from xbrl 2017-12-31.
VCEL-DEBT-13306 Warrants outstanding: 4.27 90% xbrl warrant detail from xbrl 2020-12-31.

Vericel Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Vericel Corporation.

Vericel Corporation Ownership

HolderNameConfidenceEvidence
VCEL-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 282 tracked holders.

Vericel Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SNNUF Smith & Nephew plc 100.00 2
PRFX PRF Technologies Ltd. 50.00 2
MDWD MediWound Ltd. 38.88 1 ['customer']
BLRX BioLineRx Ltd. 14.78 2